Ecdysteroids Sensitize MDR and Non-MDR Cancer Cell Lines to Doxorubicin, Paclitaxel, and Vincristine but Tend to Protect Them From Cisplatin

BioMed Research International - United States
doi 10.1155/2015/895360
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Sinomenine Sensitizes Multidrug-Resistant Colon Cancer Cells (Caco-2) to Doxorubicin by Downregulation of MDR-1 Expression

PLoS ONE
Multidisciplinary
2014English

Tuberculosis: Current Strategies to Control MDR

International Journal of Medical Research and Review
2014English

Ginkgo May Sensitize Ovarian Cancer Cells to Cisplatin

Integrative Cancer Therapies
OncologyAlternative MedicineComplementary
2012English

Guanylate-Binding Protein-1 Protects Ovarian Cancer Cell Lines but Not Breast Cancer Cell Lines From Killing by Paclitaxel

Biochemical and Biophysical Research Communications
BiochemistryCell BiologyMolecular BiologyBiophysics
2016English

Chalcones Repressed the AURKA and MDR Proteins Involved in Metastasis and Multiple Drug Resistance in Breast Cancer Cell Lines

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2018English

ErbB3 Expression Predicts Sensitivity to Elisidepsin Treatment: In�vitro Synergism With Cisplatin, Paclitaxel and Gemcitabine in Lung, Breast and Colon Cancer Cell Lines

International Journal of Oncology
Cancer ResearchOncology
2012English

Genetic Polymorphisms and Ovarian Cancer Risk and Response to Paclitaxel/Cisplatin Chemotherapy

Hereditary Cancer in Clinical Practice
OncologyGenetics
2015English

Halocynthiaxanthin and Peridinin Sensitize Colon Cancer Cell Lines to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2007English

Magnetic Nanoparticles Sensitize McF-7 Breast Cancer Cells to Doxorubicin-Induced Apoptosis

World Journal of Surgical Oncology
SurgeryOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy